Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Kanglaite Injection+Chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC
1 trial -
Ketamine
United Therapeutics Europe Ltd
Chronic Postoperative Pain
1 trial -
Ketamine Hydrochloride
NORTHWEST BIOTHERAPEUTICS INC
Revision Spine Surgery
1 trial -
Ketamine Hydrochloride
United Therapeutics Europe Ltd
Hemorrhage
1 trial -
Ketorolac Injection
United Therapeutics Europe Ltd
Orthopaedic Trauma
1 trial -
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
Almirall, S.A.
Actinic Keratosis
1 trial -
L. helveticus R0052 and B. longum R0175
Acadia Pharmaceuticals B.V.
Attention Deficit Hyperactivity Disorder
1 trial -
LACTOSE MONOHYDRATE, Clopidogrel Viatris 75 mg film coated tablets, Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten., Clopidogrel Zentiva 75 mg film-coated tablets
Disc Medicine
(Chronic) Peripheral (occlusive) arterial disease (PAD)
1 trial -
LacTEST 0,45 g polvo para solución oral.
Lacuna Pharma Pty Ltd
Lactose intolerance
1 trial -
Levobupivacaine
United Therapeutics Europe Ltd
Arthroplasty, Replacement, Knee
1 trial -
Levothyroxine
United Therapeutics Europe Ltd
Hypothyroidism
1 trial -
Liposomal Bupivacaine Infiltration
Pacira Ireland Limited
Postoperative Pain
1 trial -
Lisdexamfetamine dimesylate
Takeda
Attention-deficit/Hyperactivity Disorder
3 trials -
Lisdexamfetamine dimesylate
Takeda
Attention Deficit Hyperactivity Disorder (ADHD)
1 trial -
Lucentis
Hospital Authority, Hong Kong
Wet Macular Degeneration
1 trial -
Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets
Ningbo Cancer Hospital
Early Breast Cancer
1 trial -
MMX Mesalamine
Takeda
Ulcerative Colitis
2 trials -
MMX mesalamine/ mesalazine
Takeda
Ulcerative Colitis
1 trial -
Maggot debridement therapy
The First People's Hospital of Lianyungang
Diabetic Foot Ulcers
1 trial -
Mailed nicotine replacement therapy
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
Menjugate
United Therapeutics Europe Ltd
Meningococcal Disease
1 trial -
Mesalazine
United Therapeutics Europe Ltd
Irritable Bowel Syndrome With Diarrhoea
1 trial -
Mesalazine
The First People's Hospital of Lianyungang
Ulcerative Colitis, Unspecified
1 trial -
Metformin Actavis 500 mg filmdragerad tablett
The George Institute
Polycystic ovary syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources